| 摘要 |
<p>Disclosed is a medicament for reducing NMDA receptor-mediated neuronal damage in a mammal comprising a nitric-oxide generating compound, or a physiologically acceptable salt thereof, in a concentration effective to cause such reduction. Also disclosed is a medicament for reducing NMDA receptor-mediated neuronal damage in a mammal comprising nitroprusside, nitroglycerin, or a derivative of one of those compounds, in a concentration effective to cause such reduction.</p> |
